二甲双胍用于衰老和癌症预防。
Metformin for aging and cancer prevention.
作者信息
Anisimov Vladimir N
机构信息
Department of Carcinogenesis and Oncogerontology, N.N. Petrov Research Institute of Oncology, St. Petersburg 197758, Russia.
出版信息
Aging (Albany NY). 2010 Nov;2(11):760-74. doi: 10.18632/aging.100230.
Abstract
Studies in mammals have led to the suggestion that hyperglycemia and hyperinsulinemia are important factors in aging. Insulin/insulin-like growth factor 1 (IGF-1) signaling molecules that have been linked to longevity include daf-2 and InR and their homologues in mammals, and inactivation of the corresponding genes increases life span in nematodes, fruit flies and mice. It is possible that the life-prolonging effect of caloric restriction is due to decreasing IGF-1 levels. Evidence has emerged that antidiabetic drugs are promising candidates for both life span extension and prevention of cancer. Thus, antidiabetic drugs postpone spontaneous carcinogenesis in mice and rats, as well as chemical and radiation carcinogenesis in mice, rats and hamsters. Furthermore metformin seems to decrease cancer risk in diabetic patients.
摘要
对哺乳动物的研究表明，高血糖和高胰岛素血症是衰老的重要因素。与长寿相关的胰岛素/胰岛素样生长因子1（IGF-1）信号分子包括秀丽隐杆线虫中的daf-2和果蝇中的InR及其在哺乳动物中的同源物，相应基因的失活可延长线虫、果蝇和小鼠的寿命。热量限制的延寿作用可能是由于IGF-1水平降低。有证据表明，抗糖尿病药物有望用于延长寿命和预防癌症。因此，抗糖尿病药物可延缓小鼠和大鼠的自发癌变，以及小鼠、大鼠和仓鼠的化学和辐射致癌。此外，二甲双胍似乎可降低糖尿病患者的癌症风险。
相似文献
1
Metformin for aging and cancer prevention.
Aging (Albany NY). 2010 Nov;2(11):760-74. doi: 10.18632/aging.100230.
2
The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.
Crit Rev Oncol Hematol. 2013 Sep;87(3):201-23. doi: 10.1016/j.critrevonc.2013.01.005. Epub 2013 Feb 21.
3
Metformin: do we finally have an anti-aging drug?
Cell Cycle. 2013 Nov 15;12(22):3483-9. doi: 10.4161/cc.26928. Epub 2013 Oct 24.
4
Central and peripheral effects of insulin/IGF-1 signaling in aging and cancer: antidiabetic drugs as geroprotectors and anticarcinogens.
Ann N Y Acad Sci. 2005 Dec;1057:220-34. doi: 10.1196/annals.1356.017.
5
Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention.
Exp Gerontol. 2003 Oct;38(10):1041-9. doi: 10.1016/s0531-5565(03)00169-4.
6
[Role of the growth hormone-insulin-like growth factor-1-insulin system signaling in aging and longevity: evolutional aspect].
Ross Fiziol Zh Im I M Sechenova. 2008 Sep;94(9):1092-109.
7
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Exp Gerontol. 2005 Aug-Sep;40(8-9):685-93. doi: 10.1016/j.exger.2005.07.007.
8
Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice.
Aging (Albany NY). 2010 Dec;2(12):945-58. doi: 10.18632/aging.100245.
9
Metformin slows down aging and extends life span of female SHR mice.
Cell Cycle. 2008 Sep 1;7(17):2769-73. doi: 10.4161/cc.7.17.6625. Epub 2008 Sep 11.
10
If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice.
Aging (Albany NY). 2011 Feb;3(2):148-57. doi: 10.18632/aging.100273.
引用本文的文献
1
The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies.
Research (Wash D C). 2025 Mar 5;8:0612. doi: 10.34133/research.0612. eCollection 2025.
2
The combined treatment with ketogenic diet and metformin slows tumor growth in two mouse models of triple negative breast cancer.
Transl Med Commun. 2024;9(1). doi: 10.1186/s41231-024-00178-8. Epub 2024 Jun 22.
3
The combination of metformin and high glucose increased longevity of a DAF-16/FOXO-independent manner: cancer/diabetic model via .
Front Endocrinol (Lausanne). 2024 Nov 4;15:1435098. doi: 10.3389/fendo.2024.1435098. eCollection 2024.
4
The Combined Treatment with Ketogenic Diet and Metformin Slows Tumor Growth in Two Mouse Models of Triple Negative Breast Cancer.
Res Sq. 2023 Dec 20:rs.3.rs-3664129. doi: 10.21203/rs.3.rs-3664129/v1.
5
Lipid and glucose metabolism in senescence.
Front Nutr. 2023 Aug 23;10:1157352. doi: 10.3389/fnut.2023.1157352. eCollection 2023.
6
Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes.
Drug Des Devel Ther. 2023 Jun 26;17:1907-1932. doi: 10.2147/DDDT.S409373. eCollection 2023.
7
Therapeutic Antiaging Strategies.
Biomedicines. 2022 Oct 8;10(10):2515. doi: 10.3390/biomedicines10102515.
8
Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?
Aging Dis. 2022 Feb 1;13(1):175-214. doi: 10.14336/AD.2021.0705. eCollection 2022 Feb.
9
A Comparative Study of the Lipophilicity of Metformin and Phenformin.
Molecules. 2021 Oct 31;26(21):6613. doi: 10.3390/molecules26216613.
10
Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products.
Molecules. 2021 Apr 10;26(8):2179. doi: 10.3390/molecules26082179.
本文引用的文献
1
[Effect of metformin on the magnitude of oxidative stress in patients with type 2 diabetes mellitus].
Probl Endokrinol (Mosk). 2007 Feb 15;53(1):3-7. doi: 10.14341/probl20075313-7.
2
[Melatonin and metformin inhibit skin carcinogenesis induced by benz(a)pyrene in mice].
Vopr Onkol. 2010;56(5):583-7.
3
Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging.
Biofactors. 2010 Sep-Oct;36(5):377-82. doi: 10.1002/biof.127.
4
Metformin prevents tobacco carcinogen--induced lung tumorigenesis.
Cancer Prev Res (Phila). 2010 Sep;3(9):1066-76. doi: 10.1158/1940-6207.CAPR-10-0055. Epub 2010 Sep 1.
5
Metformin and other biguanides in oncology: advancing the research agenda.
Cancer Prev Res (Phila). 2010 Sep;3(9):1060-5. doi: 10.1158/1940-6207.CAPR-10-0175. Epub 2010 Sep 1.
6
Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond.
Future Oncol. 2010 Aug;6(8):1313-23. doi: 10.2217/fon.10.87.
7
Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells.
Curr Mol Med. 2010 Oct;10(7):674-91. doi: 10.2174/156652410792630625.
8
Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
Mol Carcinog. 2010 Jul;49(7):662-71. doi: 10.1002/mc.20637.
9
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.
Expert Rev Mol Diagn. 2010 May;10(4):509-19. doi: 10.1586/erm.10.22.
10
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.
Cell Metab. 2010 May 5;11(5):390-401. doi: 10.1016/j.cmet.2010.03.014.
Zotero 插件